Commentary: improving the use of gastroprotective agents among high-risk NSAID users - authors’ reply
Author:
Affiliation:
1. Department of Medicine & Therapeutics; The Chinese University of Hong Kong; Prince of Wales Hospital; Hong Kong; China
Publisher
Wiley
Subject
Pharmacology (medical),Gastroenterology,Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.12295/fullpdf
Reference5 articles.
1. Commentary: improving the use of gastroprotective agents among high-risk NSAID users;Howden;Aliment Pharmacol Ther,2013
2. The use of prophylactic gastroprotective therapy in patients with nonsteroidal anti-inflammatory drug- and aspirin-associated ulcer bleeding: a cross-sectional study;Ho;Aliment Pharmacol Ther,2013
3. Prescription of nonselective NSAIDs, coxibs and gastroprotective agents in the era of rofecoxib withdrawal - a 617,400-patient study;Valkhoff;Aliment Pharmacol Ther,2012
4. Gastroprotective drugs in Australia: utilization patterns between 1997 and 2006 in relation to NSAID prescribing;Barozzi;Clin Ther,2009
5. Editorial: single-tablet ibuprofen/double-dose famotidine for reduction of gastric and duodenal ulcers (REDUCE Trials): what can be reduced?;Chan;Am J Gastroenterol,2012
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3